RNR Healthcare, Led by CEO Vicky Ramancha, to Open Pharmaceutical Trading Entity in the US

New York, New York--(Newsfile Corp. - October 9, 2023) - RNR Healthcare CEO Vicky Ramancha has announced to be entering USA market with pharmaceutical licensed trading entity. RNR Healthcare is currently under process of acquiring pharmaceutical license and will be opening up offices and operational units in the US to be estimated in the first quarter of 2024.

 
Vicky Ramancha, Chief Executive Officer of RNR Healthcare
 
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10000/183339_8d8a24ab748119e5_001full.jpg

Vicky Ramancha, Chief Executive Officer of RNR Healthcare, has announced that the firm is preparing market entry strategy and operations for the US market as soon as pharmaceutical license will be granted.

RNR Healthcare is estimating to be fully operational in the US market by the 2nd quarter of 2024.

About RNR Healthcare

RNR Healthcare is a global pharmaceutical and medical equipment trading company specializing in sourcing and procuring in high demand pharmaceutical and medical products.

Contact
Vicky Ramancha
global.business@rnr.healthcare
rnr.healthcare

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/183339